Enhabit (NYSE:EHAB) Given "Market Perform" Rating at Leerink Partners

Leerink Partners restated their market perform rating on shares of Enhabit (NYSE:EHAB - Free Report) in a research report report published on Tuesday,Benzinga reports. The brokerage currently has a $8.00 price objective on the stock, down from their previous price objective of $8.50.

Enhabit Price Performance

Enhabit stock traded up $0.12 during midday trading on Tuesday, reaching $7.27. 357,923 shares of the stock were exchanged, compared to its average volume of 581,143. The company's fifty day moving average is $7.54 and its 200-day moving average is $8.43. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. The firm has a market cap of $365.31 million, a PE ratio of -3.13 and a beta of 1.84. Enhabit has a 52 week low of $6.85 and a 52 week high of $11.74.

Enhabit (NYSE:EHAB - Get Free Report) last posted its earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing analysts' consensus estimates of $0.04 by ($0.01). The firm had revenue of $253.60 million for the quarter, compared to the consensus estimate of $261.69 million. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. During the same period last year, the company posted $0.03 EPS. On average, sell-side analysts forecast that Enhabit will post 0.25 EPS for the current year.

Insider Activity

In other news, Director Jeffrey Bolton bought 5,000 shares of the company's stock in a transaction that occurred on Thursday, August 22nd. The stock was bought at an average price of $8.01 per share, for a total transaction of $40,050.00. Following the transaction, the director now directly owns 78,877 shares of the company's stock, valued at $631,804.77. This represents a 6.77 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 1.90% of the company's stock.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in EHAB. Allspring Global Investments Holdings LLC purchased a new position in shares of Enhabit during the first quarter worth approximately $44,000. ProShare Advisors LLC purchased a new position in shares of Enhabit during the first quarter worth approximately $118,000. State Board of Administration of Florida Retirement System raised its stake in shares of Enhabit by 268.2% during the first quarter. State Board of Administration of Florida Retirement System now owns 52,932 shares of the company's stock worth $617,000 after acquiring an additional 38,555 shares in the last quarter. Orion Portfolio Solutions LLC raised its stake in shares of Enhabit by 72.5% during the first quarter. Orion Portfolio Solutions LLC now owns 96,833 shares of the company's stock worth $1,128,000 after acquiring an additional 40,684 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its holdings in Enhabit by 5.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 37,950 shares of the company's stock valued at $443,000 after acquiring an additional 2,078 shares during the period.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.